SCIRP Mobile Website
Paper Submission

Why Us? >>

  • - Open Access
  • - Peer-reviewed
  • - Rapid publication
  • - Lifetime hosting
  • - Free indexing service
  • - Free promotion service
  • - More citations
  • - Search engine friendly

Free SCIRP Newsletters>>

Add your e-mail address to receive free newsletters from SCIRP.

 

Contact Us >>

Article citations

More>>

C.-H. Wu, C.-M. Huang, C.-H. Lin, Y.-S. Ho, C.-M. Chen and H.-M. Lee, “Advanced Glycosylation End Products Induce NF-κB Dependent iNOS Expression in RAW 264.7 Cells,” Molecular and Cellular Endocrinology, Vol. 194, 2002, pp. 9-17.

has been cited by the following article:

  • TITLE: Inhibitory Effects of Several Spices on Inflammation Caused by Advanced Glycation Endproducts

    AUTHORS: Su-Chen Ho, Pei-Wen Chang

    KEYWORDS: Advanced Glycation End-Products; Diabetic Complication; Inflammation; Spices

    JOURNAL NAME: American Journal of Plant Sciences, Vol.3 No.7A, July 17, 2012

    ABSTRACT: Advanced glycation endproducts (AGEs) is implicated in the pathogenesis of diabetic complications. Inhibiting the formation of AGEs and interfering with AGEs-mediated inflammation are two practicable strategies for developing a dietary adjuvant against diabetic complications. This study evaluated the protective capacities against diabetic complications of several spices based on their inhibition of the formation of AGEs in an in vitro BSA/glucose system and on the AGEs-induced production of proinflammatory cytokine in RAW 264.7 macrophages. Among the tested spices, cinnamon exhibited most strongly inhibited both the formation of AGEs and the AGEs-induced production of nitric oxide, interleukin-6 and tumor necrosis factor-α. Additionally, correlative results revealed that the capacity of spices to inhibit the formation of AGEs is attributable to phenolic compounds and, in contrast, the capacity to inhibit AGEs-induced inflammation is attributable to condensed tannin. This investigation demonstrates the potential of cinnamon to serve as a dietary adjuvant against diabetic complications.